English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech BioTech
透云生物旗下「莱茵衣藻」获批为国家新食品原料
May 16, 2022 09:38 HKT
透雲生物旗下「萊茵衣藻」獲批為國家新食品原料
May 16, 2022 09:37 HKT
祝贺!国际顶级医学期刊《自然-医学》同时发表两篇关于华领医药全球首创糖尿病新药多格列艾汀的III期研究结果的同行评议论文
May 13, 2022 11:18 HKT
祝賀!國際頂級醫學期刊《自然-醫學》同時發表兩篇關於華領醫藥全球首創糖尿病新藥多格列艾汀的III期研究結果的同行評議論文
May 13, 2022 11:17 HKT
Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine
May 13, 2022 11:16 HKT
노보텍, 프리-ASCO중국 서밋 후원: 초기 단계 종양학 임상에 기반해 진행 여부 결정
May 12, 2022 21:00 HKT
Q&M Dental net profit, excluding other gains or losses, increased by 25% to S$7.2 million on S$46.8 million of revenue for quarter ended 31 March 2022
May 12, 2022 09:00 HKT
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
May 12, 2022 06:00 HKT
Novotech 赞助 ASCO 中国峰会前夕:基于早期肿瘤学试验的 Go/No Go 决策
May 12, 2022 06:00 HKT
Novotech 贊助 ASCO 中國峰會前夕:基於早期腫瘤學試驗的 Go/No Go 決策
May 12, 2022 06:00 HKT
Sirnaomics在TIDES USA 2022上汇报其基于GalNAc-肝脏靶向技术平台和GalAhead™技术及相关项目的最新进展
May 11, 2022 14:35 HKT
Sirnaomics在TIDES USA 2022上匯報其基於GalNAc-肝臟靶向技術平台和GalAhead™技術及相關項目的最新進展
May 11, 2022 14:34 HKT
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead(TM) Programs at the TIDES USA 2022
May 11, 2022 14:33 HKT
노보텍, 미국 임상시험수탁기관 인수 - 글로벌 전문성 확대
May 05, 2022 09:00 HKT
Novotech Acquires US CRO NCGS, Expands Global Expertise
May 05, 2022 09:00 HKT
Novotech收购美国合同研究组织(CRO),拓展全球专业领域
May 05, 2022 09:00 HKT
Novotech收購美國合同研究組織(CRO),拓展全球專業領域
May 05, 2022 09:00 HKT
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry
May 05, 2022 04:05 HKT
Malaysian Genomics Resource Centre Berhad Supports Yayasan Seri Negara's Ramadhan Initiative
Apr 28, 2022 11:30 HKT
Legend Capital's Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis
Apr 27, 2022 16:09 HKT
Next >>
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: